Check out your Company Bowl for anonymous work chats.
Grifols Diagnostic Solutions featured in the San Francisco Business Times Grifols Diagnostic Solutions was recently featured in a supplement to the SF Business Times! Quoting leadership from the Diagnostic Commercial Division, the article discusses Grifols’ commitment to the Bay Area region, future plans for investment in the Emeryville site and its social impact on the neighboring communities. Click here to read the article: http://glassdoor.com/slink.htm?key=vQOhs
Grifols has broken new ground in the fight against Alzheimer’s disease. We recently announced the success of AMBAR, a Phase IIb/III clinical trial aimed at slowing the progression of Alzheimer’s disease. Visit our new website to read more about the promising results, which show that AMBAR provides hope for a new treatment pathway for moderate Alzheimer's patients: http://glassdoor.com/slink.htm?key=vQJ28
